Novel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Disease
Metadatos
Afficher la notice complèteAuteur
González Lozano, Elena; García García, Jorge; Gálvez Peralta, Julio Juan; Hidalgo García, Laura; Rodríguez Nogales, Alba; Rodríguez Cabezas, María Elena; Sánchez Santos, ManuelEditorial
MDPI
Materia
EVs IBD Immunomodulation Inflammation Lactobacillus Postbiotics Probiotics
Date
2022-12-13Referencia bibliográfica
González-Lozano, E... [et al.]. Novel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Disease. Nutrients 2022, 14, 5296. [https://doi.org/10.3390/nu14245296]
Patrocinador
Junta de Andalucia CTS 164 PY20_01157; Instituto de Salud Carlos III European Commission PI19/01058 European CommissionRésumé
Lactobacillus probiotics contained in dietary supplements or functional foods are wellknown
for their beneficial properties exerted on host health and diverse pathological situations. Their
capacity to improve inflammatory bowel disease (IBD) and regulate the immune system is especially
remarkable. Although bacteria–host interactions have been thought to occur directly, the key role that
extracellular vesicles (EVs) derived from probiotics play on this point is being unveiled. EVs are lipid
bilayer-enclosed particles that carry a wide range of cargo compounds and act in different signalling
pathways. Notably, these EVs have been recently proposed as a safe alternative to the utilisation of
live bacteria since they can avoid the possible risks that probiotics may entail in vulnerable cases
such as immunocompromised patients. Therefore, this review aims to give an updated overview of
the existing knowledge about EVs from different Lactobacillus strains, their mechanisms and effects in
host health and different pathological conditions. All of the information collected suggests that EVs
could be considered as potential tools for the development of future novel therapeutic approaches.